Skip to main content
. 2010 Nov 14;2011:213135. doi: 10.1155/2011/213135

Figure 3.

Figure 3

Structure of three competitive HCV helicase inhibitors ribavirin 5′-triphosphate (1), ribavirin 5′-diphosphate (2), and paclitaxel (3).